Drugs.com - New Drug Approvals

U.S. FDA Approves Tablet Formulation of BeOne’s Brukinsa for All Approved Indications

SAN CARLOS, Calif.--(BUSINESS WIRE) Jun 11, 2025 -- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of...

Jun 12, 2025 - 03:00
 0
U.S. FDA Approves Tablet Formulation of BeOne’s Brukinsa for All Approved Indications
SAN CARLOS, Calif.--(BUSINESS WIRE) Jun 11, 2025 -- BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of...
Read More

Tags:

Previous Article

Question of the Day: What's Your Forgotten Model?

Next Article

Opinion: By remaking CDC’s vaccine advisory panel, RFK Jr. is destroying public ...

Related Posts

FDA Approves Enflonsia (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants

FDA Approves Enflonsia (clesrovimab-cfor) for Preventio...

Jun 9, 2025  0

FDA Approves Pembrolizumab for HER2 Positive Gastric or...

May 12, 2025  0

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) a...

May 12, 2025  0